Although the CTNNB1 mutation represents an important event leading to the tumorigenesis of hepatocytes, a mouse model overexpressing the liver-cancer associated β-catenin mutant showed that β-catenin itself was not sufficient to induce HCC [14]. The gene discussed is CTNNB1; the disease is liver cancer.